Log In
Print
BCIQ
Print
Print this Print this
 

SL-701

  Manage Alerts
Collapse Summary General Information
Company Stemline Therapeutics Inc.
DescriptionCancer vaccine comprised of synthetic peptides administered via subcutaneous injection
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme (GBM); Treat newly diagnosed and recurrent adult low-grade glioma; Treat newly diagnosed and recurrent pediatric glioma; Treat recurrent and refractory adult high-grade glioma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today